During the past decade, First Affiliated Hospital of Xiamen University conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 3 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 3 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "First Affiliated Hospital of Xiamen University" #1 sponsor was "The First Affiliated Hospital of Xiamen University" with 8 trials, followed by "BeiGene" with 6 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials sponsored and "Genor Biopharma Co., Ltd." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "First Affiliated Hospital of Xiamen University" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Eastern Hepatobiliary Surgery Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "LanZhou University" with 1 trials as a collaborator and "Tigermed Consulting Co., Ltd" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "First Affiliated Hospital of Xiamen University" are "Stroke" (2 trials), "177Lu-DOTA-FAPI" (1 trials), "68Ga-DOTA-FAPI" (1 trials), "Advanced Non-small Cell Lung Cancer" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "First Affiliated Hospital of Xiamen University" in a lesser frequency.

Most popular intervention types in "First Affiliated Hospital of Xiamen University" are "Drug" (17 trials), "Diagnostic Test" (2 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tislelizumab" (5 trials), "Placebo" (3 trials), "Cisplatin" (2 trials), "Placebos" (2 trials) and "18F-FDG PET/CT and PET/CT-guide targeted biopsy in another group of participants" (1 trials). Other intervention names were less common.

The vast majority of trials in "First Affiliated Hospital of Xiamen University" are 20 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "First Affiliated Hospital of Xiamen University". 1 are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in First Affiliated Hospital of Xiamen University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in First Affiliated Hospital of Xiamen University, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".